Literature DB >> 19901067

CXCL10 production by human monocytes in response to Leishmania braziliensis infection.

Diego A Vargas-Inchaustegui1, Alison E Hogg, Gianfranco Tulliano, Alejandro Llanos-Cuentas, Jorge Arevalo, Janice J Endsley, Lynn Soong.   

Abstract

Leishmania (subgenus Viannia) braziliensis is the causative agent of mucocutaneous leishmaniasis (ML) in South America, and ML is characterized by excessive T- and B-cell responses to the parasite. We speculate that the unbalanced production of inflammatory mediators in response to L. braziliensis infection contributes to cell recruitment and disease severity. To test this hypothesis, we first examined the response of peripheral blood mononuclear cells (PBMCs) from healthy volunteers to L. braziliensis infection. We observed that while L. braziliensis infection induced the production of chemokine (C-X-C motif) ligand 10 (CXCL10) and interleukin-10 (IL-10) in human PBMCs and macrophages (MPhis), enhanced expression of CXCL10 and its receptor, chemokine CXC receptor (CXCR3), was predominantly detected in CD14(+) monocytes. The chemoattractant factors secreted by L. braziliensis-infected cells were highly efficient in recruiting uninfected PBMCs (predominantly CD14(+) cells) through Transwell membranes. Serum samples from American tegumentary leishmaniasis (ATL) patients (especially the ML cases) had significantly higher levels of CXCL10, CCL4, and soluble tumor necrosis factor (TNF) receptor II (sTNFRII) than did those of control subjects. Our results suggest that, following L. braziliensis infection, the production of multiple inflammatory mediators by the host may contribute to disease severity by increasing cellular recruitment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19901067      PMCID: PMC2798186          DOI: 10.1128/IAI.00959-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

Review 1.  Migration of dendritic cells across blood and lymphatic endothelial barriers.

Authors:  Annalisa Del Prete; Massimo Locati; Karel Otero; Elena Riboldi; Alberto Mantovani; Annunciata Vecchi; Silvano Sozzani
Journal:  Thromb Haemost       Date:  2006-01       Impact factor: 5.249

2.  CXCL10/gamma interferon-inducible protein 10-mediated protection against Leishmania amazonensis infection in mice.

Authors:  Rene E Vasquez; Lynn Soong
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

3.  Human rhinovirus induces robust IP-10 release by monocytic cells, which is independent of viral replication but linked to type I interferon receptor ligation and STAT1 activation.

Authors:  Nichole L Korpi-Steiner; Mary Ellen Bates; Wai-Ming Lee; David J Hall; Paul J Bertics
Journal:  J Leukoc Biol       Date:  2006-10-04       Impact factor: 4.962

4.  Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis.

Authors:  Asrat Hailu; Tom van der Poll; Nega Berhe; Piet A Kager
Journal:  Am J Trop Med Hyg       Date:  2004-11       Impact factor: 2.345

Review 5.  Cutaneous Leishmania infection: progress in pathogenesis research and experimental therapy.

Authors:  Esther von Stebut
Journal:  Exp Dermatol       Date:  2007-04       Impact factor: 3.960

Review 6.  Cutaneous leishmaniasis.

Authors:  Richard Reithinger; Jean-Claude Dujardin; Hechmi Louzir; Claude Pirmez; Bruce Alexander; Simon Brooker
Journal:  Lancet Infect Dis       Date:  2007-09       Impact factor: 25.071

7.  Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.

Authors:  Jorge Arevalo; Luis Ramirez; Vanessa Adaui; Mirko Zimic; Gianfranco Tulliano; César Miranda-Verástegui; Marcela Lazo; Raúl Loayza-Muro; Simonne De Doncker; Anne Maurer; Francois Chappuis; Jean-Claude Dujardin; Alejandro Llanos-Cuentas
Journal:  J Infect Dis       Date:  2007-05-03       Impact factor: 5.226

8.  Leishmania amazonensis infection impairs differentiation and function of human dendritic cells.

Authors:  Cecilia Favali; Natália Tavares; Jorge Clarêncio; Aldina Barral; Manoel Barral-Netto; Claudia Brodskyn
Journal:  J Leukoc Biol       Date:  2007-09-21       Impact factor: 4.962

9.  Inhibition of groups 1 and 2 CD1 molecules on human dendritic cells by Leishmania species.

Authors:  M J Donovan; A Jayakumar; M A McDowell
Journal:  Parasite Immunol       Date:  2007-10       Impact factor: 2.280

Review 10.  Leishmania species: models of intracellular parasitism.

Authors:  J Alexander; A R Satoskar; D G Russell
Journal:  J Cell Sci       Date:  1999-09       Impact factor: 5.285

View more
  28 in total

1.  Host-pathogen interaction: Culprit within a culprit.

Authors:  Martin Olivier
Journal:  Nature       Date:  2011-03-10       Impact factor: 49.962

2.  Phenotypic and functional characteristics of HLA-DR+ neutrophils in Brazilians with cutaneous leishmaniasis.

Authors:  Richard E Davis; Smriti Sharma; Jacilara Conceição; Pedro Carneiro; Fernanda Novais; Phillip Scott; Shyam Sundar; Olivia Bacellar; Edgar M Carvalho; Mary E Wilson
Journal:  J Leukoc Biol       Date:  2016-10-17       Impact factor: 4.962

Review 3.  The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis.

Authors:  Mary-Anne Hartley; Stefan Drexler; Catherine Ronet; Stephen M Beverley; Nicolas Fasel
Journal:  Trends Parasitol       Date:  2014-06-20

Review 4.  Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis.

Authors:  Lynn Soong; Calvin A Henard; Peter C Melby
Journal:  Semin Immunopathol       Date:  2012-10-11       Impact factor: 9.623

5.  MicroRNA 155 Contributes to Host Immunity against Leishmania donovani but Is Not Essential for Resolution of Infection.

Authors:  Sanjay Varikuti; Gayathri Natarajan; Greta Volpedo; Bhawana Singh; Omar Hamza; Gretchen V Messick; Mireia Guerau-de-Arellano; Tracey L Papenfuss; Steve Oghumu; Abhay R Satoskar
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

6.  Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis.

Authors:  Annette Ives; Catherine Ronet; Florence Prevel; Giulia Ruzzante; Silvia Fuertes-Marraco; Frederic Schutz; Haroun Zangger; Melanie Revaz-Breton; Lon-Fye Lye; Suzanne M Hickerson; Stephen M Beverley; Hans Acha-Orbea; Pascal Launois; Nicolas Fasel; Slavica Masina
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

7.  Muco-cutaneous leishmaniasis in the New World: the ultimate subversion.

Authors:  Catherine Ronet; Stephen M Beverley; Nicolas Fasel
Journal:  Virulence       Date:  2011-11-01       Impact factor: 5.882

8.  Immunity to Lutzomyia intermedia saliva modulates the inflammatory environment induced by Leishmania braziliensis.

Authors:  Tatiana R de Moura; Fabiano Oliveira; Gabriele C Rodrigues; Marcia W Carneiro; Kiyoshi F Fukutani; Fernanda O Novais; José Carlos Miranda; Manoel Barral-Netto; Claudia Brodskyn; Aldina Barral; Camila I de Oliveira
Journal:  PLoS Negl Trop Dis       Date:  2010-06-15

9.  The Use of Antibody Arrays in the Discovery of New Plasma Biomarkers for Endometriosis.

Authors:  Dorien O; Etienne Waelkens; Arne Vanhie; Daniëlle Peterse; Amelie Fassbender; Thomas D'Hooghe
Journal:  Reprod Sci       Date:  2020-02-03       Impact factor: 3.060

10.  Toxocara canis Infection Alters lncRNA and mRNA Expression Profiles of Dog Bone Marrow.

Authors:  Wen-Bin Zheng; Yang Zou; Qing Liu; Min-Hua Hu; Hany M Elsheikha; Xing-Quan Zhu
Journal:  Front Cell Dev Biol       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.